Several lots of the cholesterol medication atorvastatin were recalled after failed dissolution tests, according to the FDA.

Ascend Wellness Holdings, Inc. (AAWH) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.1. This compares to a loss of $0.13 per share a year ago.

Q3 2025 Management View CEO Samuel Brill stated that "the industry landscape remains consistent with last quarter" and emphasized ongoing challenges including intensified competition and sector-wide ...

A New Jersey-based pharmaceutical company recalled over 100,000 bottles of statin due to "failed dissolution specifications," according to the USDA.

More than 140,000 bottles of a popular drug commonly prescribed to reduce cholesterol have been recalled for a defect that ...

Nashville's Ascend Amphitheater outdoor concert event venue will be operated by Opry Entertainment Group for the next 10 ...

Ascend Wellness Holdings, Inc. ("AWH," "Ascend," or the "Company") (CSE: AAWH.U) (OTCQX: AAWH), a leading, multi-state, ...